Form 4: BBWI Director Symancyk Buys 22,500 Shares

Bath & Body Works Director James Kevin Symancyk acquired 22,500 shares of common stock at a weighted average price of $15.58.

Summary

• James Kevin Symancyk, a Director of Bath & Body Works, Inc. (BBWI), purchased 22,500 shares of the company's common stock.
• The transaction occurred on November 24, 2025, and was executed under a Rule 10b5-1 plan.
• The shares were acquired at a weighted average price of $15.58 per share, with prices ranging from $15.575 to $15.58.
• Following this transaction, Symancyk beneficially owns a total of 40,379 shares of Bath & Body Works common stock.

Sentiment

Score: 7

Explanation: A director's purchase of company stock is generally viewed as a positive signal, indicating confidence in the company's prospects and current valuation.

Positives

• A director's purchase of company stock signals confidence in the company's future performance and valuation.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-planned investment strategy.

Future Outlook

NA

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator, suggesting that management believes the stock is undervalued or expects future growth, potentially boosting investor confidence.

Next Steps

• The reporting person will provide full information about the number of shares purchased at each separate price upon request by the SEC staff, the Issuer, or a security holder of the Issuer.

Key Dates

Recommendation

The purchase of a significant block of shares by a director, especially under a 10b5-1 plan, signals strong insider confidence in the company's future performance and intrinsic value. This direct investment aligns management's interests with shareholders and can be interpreted as a bullish signal for the stock.

Keywords

Bath & Body Works, BBWI, Insider Trading, Form 4, Stock Purchase, Director, James Kevin Symancyk, Equity Acquisition